Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms
Although advances in treatment options for patients with hematologic malignancies are encouraging, the rapidly changing scientific and clinical environment represents a daunting challenge for practitioners.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Current Approaches to Initial Treatment of Newly Diagnosed Multiple Myeloma
The number of treatment options for both transplant eligible and transplant ineligible patients continues to grow year after year.  Regimens previously approved in the second-line setting are proving to be efficacious as primary therapy.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Emerging Options and Sequencing Therapies for Relapsed Multiple Myeloma
Promising clinical responses have even been seen in heavily pretreated patients, suggesting that the new therapeutic options benefit those who have exhausted all traditional lines of therapy.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
CAR T-Cell Therapy: Recent Advances and Future Considerations
Patients with relapsed or refractory (R/R) cancers have a poor prognosis and limited treatment options.
Category
  • Acute Lymphoblastic Leukemia
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
Format
  • Recorded Webcast
Credits
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Keynote Session: Patient Experience with Innovative Therapies
The development of new and innovative cancer treatments has expanded the options available to manage patients with cancer.  However, with these advances come challenges for healthcare providers and patients.
Category
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
  • Palliative Care
  • Supportive Care Topics
  • Survivorship
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Clinical Updates: Primary Therapy of Multiple Myeloma
The FDA approvals of new regimens and new agents for supportive care including bone-directed therapy have led to rapid updates to the NCCN Guidelines for Multiple Myeloma.1 The American Cancer Society has estimated 30,770 people will be diagnosed with MM a
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma
Management of Multiple Myeloma
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation